within Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L01X_OtherAntineoplasticAgents.L01XH04_Belinostat;

model Belinostat
  extends Pharmacolibrary.Drugs.ATC.L.L01XH04;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>L01XH04</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Belinostat is a histone deacetylase (HDAC) inhibitor used primarily for the treatment of relapsed or refractory peripheral T-cell lymphoma. It has received FDA approval for this indication and is used as an antineoplastic agent in oncology.</p><h4>Pharmacokinetics</h4><p>Population pharmacokinetics in adult patients with advanced solid tumors or hematologic malignancies following intravenous infusion. The study population included both male and female patients.</p><h4>References</h4><ol><li><p>Calvo, E, et al., &amp; Allen, LF (2016). Pharmacokinetics, metabolism, and excretion of (14)C-labeled belinostat in patients with recurrent or progressive malignancies. <i>Investigational new drugs</i> 34(2) 193–201. DOI:<a href=\"https://doi.org/10.1007/s10637-015-0321-8\">10.1007/s10637-015-0321-8</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/26769244/\">https://pubmed.ncbi.nlm.nih.gov/26769244</a></p></li><li><p>Bailey, H, et al., &amp; Agarwal, N (2016). A phase I study to determine the pharmacokinetics and urinary excretion of belinostat and metabolites in patients with advanced solid tumors. <i>Cancer chemotherapy and pharmacology</i> 78(5) 1059–1071. DOI:<a href=\"https://doi.org/10.1007/s00280-016-3167-7\">10.1007/s00280-016-3167-7</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/27744565/\">https://pubmed.ncbi.nlm.nih.gov/27744565</a></p></li><li><p>McDermott, J, &amp; Jimeno, A (2014). Belinostat for the treatment of peripheral T-cell lymphomas. <i>Drugs of today (Barcelona, Spain : 1998)</i> 50(5) 337–345. DOI:<a href=\"https://doi.org/10.1358/dot.2014.50.5.2138703\">10.1358/dot.2014.50.5.2138703</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/24918834/\">https://pubmed.ncbi.nlm.nih.gov/24918834</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Belinostat;
